Cargando…

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, An-Wen, Tetzlaff, Jennifer M, Gøtzsche, Peter C, Altman, Douglas G, Mann, Howard, Berlin, Jesse A, Dickersin, Kay, Hróbjartsson, Asbjørn, Schulz, Kenneth F, Parulekar, Wendy R, Krleža-Jerić, Karmela, Laupacis, Andreas, Moher, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2013
Materias:	Research Methods & Reporting
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541470/ https://www.ncbi.nlm.nih.gov/pubmed/23303884 http://dx.doi.org/10.1136/bmj.e7586

Ejemplares similares

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
por: Page, Matthew J, et al.
Publicado: (2021)

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
por: Moher, David, et al.
Publicado: (2010)

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
por: Liberati, Alessandro, et al.
Publicado: (2009)

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
por: Liberati, Alessandro, et al.
Publicado: (2009)

Author's Reply
por: Krleža-Jerić, Karmela
Publicado: (2006)

Clinical Trial Registration: The Differing Views of Industry, the WHO, and the Ottawa Group
por: Krleža-Jerić, Karmela
Publicado: (2005)

Correction: Author's Reply
por: Krleža-Jerić, Karmela
Publicado: (2006)

CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration
por: Hopewell, Sally, et al.
Publicado: (2008)

CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials
por: Grant, Sean, et al.
Publicado: (2018)

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
por: Vandenbroucke, Jan P, et al.
Publicado: (2007)

SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials
por: Calvert, Melanie, et al.
Publicado: (2021)

Compliance of clinical trial registries with the World Health Organization minimum data set: a survey
por: Moja, Lorenzo P, et al.
Publicado: (2009)

FIRST BH COCHRANE SYMPOSIUM HELD
por: Mahmic-Kaknjo, Mersiha, et al.
Publicado: (2016)

Setting the IMPACT (IMProve Access to Clinical Trial data) Observatory baseline
por: Mahmić-Kaknjo, Mersiha, et al.
Publicado: (2018)

Do trialists endorse clinical trial registration? Survey of a Pubmed sample
por: Reveiz, Ludovic, et al.
Publicado: (2007)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
por: Altman, Douglas G, et al.
Publicado: (2012)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
por: Altman, Douglas G., et al.
Publicado: (2012)

Sharing individual participant data from clinical studies: a cross-sectional online survey among Italian patient and citizen groups
por: Colombo, Cinzia, et al.
Publicado: (2019)

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols
por: Chan, An-Wen, et al.
Publicado: (2008)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
por: Sauerbrei, Willi, et al.
Publicado: (2018)

The Use of Electronic Data Capture Tools in Clinical Trials: Web-Survey of 259 Canadian Trials
por: El Emam, Khaled, et al.
Publicado: (2009)

Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
por: Welch, Vivian, et al.
Publicado: (2015)

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration
por: Turner, Lucy, et al.
Publicado: (2013)

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
por: Cohen, Jérémie F, et al.
Publicado: (2016)

Ghost Authorship in Industry-Initiated Randomised Trials
por: Gøtzsche, Peter C, et al.
Publicado: (2007)

Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups
por: Madsen, Matias Vested, et al.
Publicado: (2009)

Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention
por: Krogsbøll, Lasse Theis, et al.
Publicado: (2009)

Divine intervention? A Cochrane review on intercessory prayer gone beyond science and reason
por: Jørgensen, Karsten Juhl, et al.
Publicado: (2009)

Evaluation of repositories for sharing individual-participant data from clinical studies
por: Banzi, Rita, et al.
Publicado: (2019)

PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
por: Zhang, Xuan, et al.
Publicado: (2020)

Correction: Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study
por: Lundh, Andreas, et al.
Publicado: (2011)

Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study
por: Lundh, Andreas, et al.
Publicado: (2010)

The standards of reporting trials in pets (PetSORT): Explanation and elaboration
por: Sargeant, Jan M., et al.
Publicado: (2023)

Guidance for Developers of Health Research Reporting Guidelines
por: Moher, David, et al.
Publicado: (2010)

Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study
por: Maund, Emma, et al.
Publicado: (2014)

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
por: Janssens, A Cecile JW, et al.
Publicado: (2011)

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
por: Janssens, A. Cecile J. W., et al.
Publicado: (2011)

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
por: McShane, Lisa M, et al.
Publicado: (2013)

Standards for Reporting Implementation Studies (StaRI): explanation and elaboration document
por: Pinnock, Hilary, et al.
Publicado: (2017)

Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
por: Percie du Sert, Nathalie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tfvqesnl1s72u2a5u0hu9v1ue1